These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34138128)

  • 1. One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy.
    Hong C; Liang J; Xia J; Zhu Y; Guo Y; Wang A; Lu C; Ren H; Chen C; Li S; Wang D; Zhan H; Wang J
    Nanomicro Lett; 2020 Jun; 12(1):129. PubMed ID: 34138128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
    Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J
    Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2.
    Ao H; Song H; Li J; Wang X
    Drug Deliv; 2024 Dec; 31(1):2324716. PubMed ID: 38555735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer.
    Hong C; Wang D; Liang J; Guo Y; Zhu Y; Xia J; Qin J; Zhan H; Wang J
    Theranostics; 2019; 9(15):4437-4449. PubMed ID: 31285771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance.
    Xia J; Chen C; Dong M; Zhu Y; Wang A; Li S; Zhang R; Feng C; Jiang X; Xu X; Wang J
    J Control Release; 2023 Dec; 364():23-36. PubMed ID: 37863358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR-Targeted Liposomes Combined with Ginsenoside Rh2 Inhibit Triple-Negative Breast Cancer Growth and Metastasis.
    Gu H; Shi R; Xu C; Lv W; Hu X; Xu C; Pan Y; He X; Wu A; Li J
    Bioconjug Chem; 2023 Jun; 34(6):1157-1165. PubMed ID: 37235785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
    Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
    Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes.
    Xia J; Zhang S; Zhang R; Wang A; Zhu Y; Dong M; Ma S; Hong C; Liu S; Wang D; Wang J
    J Nanobiotechnology; 2022 Sep; 20(1):414. PubMed ID: 36109762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy.
    Liang H; Zou F; Liu Q; Wang B; Fu L; Liang X; Liu J; Liu Q
    Int J Pharm; 2021 Apr; 599():120418. PubMed ID: 33647414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor accumulation and therapeutic efficacy of liposomal drugs through over-threshold dosing.
    Ao H; Wang Z; Lu L; Ma H; Li H; Fu J; Li M; Han M; Guo Y; Wang X
    J Nanobiotechnology; 2022 Mar; 20(1):137. PubMed ID: 35292036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the structure of ginsenosides on the
    Chen C; Xia J; Ren H; Wang A; Zhu Y; Zhang R; Gan Z; Wang J
    Asian J Pharm Sci; 2022 Mar; 17(2):219-229. PubMed ID: 35582640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel saponin liposomes based on the couplet medicines of
    Guo C; Su Y; Wang H; Cao M; Diao N; Liu Z; Chen D; Kong M
    Drug Deliv; 2022 Dec; 29(1):2743-2750. PubMed ID: 35999702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes.
    Chen IJ; Cheng YA; Ho KW; Lin WW; Cheng KW; Lu YC; Hsieh YC; Huang CC; Chuang CH; Chen FM; Su YC; Roffler SR; Cheng TL
    Acta Biomater; 2020 Jul; 111():386-397. PubMed ID: 32417267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteria-targeting liposomes for enhanced delivery of cinnamaldehyde and infection management.
    Sang N; Jiang L; Wang Z; Zhu Y; Lin G; Li R; Zhang J
    Int J Pharm; 2022 Jan; 612():121356. PubMed ID: 34919996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
    Rait AS; Pirollo KF; Xiang L; Ulick D; Chang EH
    Mol Med; 2002 Aug; 8(8):475-86. PubMed ID: 12435858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
    Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
    Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
    Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
    Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.